Page last updated: 2024-08-24

gemcitabine and lrrk2-in1

gemcitabine has been researched along with lrrk2-in1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamano, K; Harada, E; Hosoyama, T; Kawamura, D; Kugimiya, N; Nishimoto, A; Shirasawa, B; Takemoto, Y; Tanaka, T; Ueno, K	1

Other Studies

1 other study(ies) available for gemcitabine and lrrk2-in1

Article	Year
Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Oncology reports, 2017, Volume: 38, Issue:5 Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Benzodiazepinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Deoxycytidine; Doublecortin-Like Kinases; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Neoplasm Proteins; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction	2017

Article

Year

Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.

Oncology reports, 2017, Volume: 38, Issue:5

Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Benzodiazepinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Deoxycytidine; Doublecortin-Like Kinases; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Neoplasm Proteins; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction

2017